Brazil Cancer Therapy Market - Forecast(2022 - 2027)

Report Code: HCR 1259 Report Format: PDF + Excel

Brazil Cancer Therapy Market Overview

The Brazil Cancer Therapy market size is estimated to reach $1.9 billion by 2027, growing at a CAGR of 8.1% during the forecast period 2022-2027. Cancer therapy involves the use of surgical or non-surgical procedures for the treatment of various cancers. A patient suffering from cancer can receive many different types of therapies, including treatment designed for reducing cancer symptoms, such as pain and fatigue. Some of the commonly used therapeutic procedures for cancer include chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and radiation therapy. Few of the most prevalent cancer types in Brazil include breast cancer, prostate cancer, lung cancer, and colorectum cancer. The rapid rise in the geriatric population is anticipated to drive the market during the forecast period. However, the COVID-19 pandemic is projected to hamper the number of cancer diagnostic and therapeutic procedures conducted during the forecast period.

Report Coverage

The report: “Brazil Cancer Therapy Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Brazil Cancer Therapy Market.

By Cancer Type: Blood Cancer, Bone Cancer, Skin Cancer, Breast Cancer, Colorectal Cancer, Oral Cancer, Gastrointestinal Cancer, Prostate Cancer, Kidney Cancer, Endocrine Cancer, Respiratory Cancer, and Others.
By Treatment Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, and Other Treatment Types.
By Distribution Channel: Hospitals, Clinics, Cancer and Radiation Therapy Centers, Retail Pharmacies, and Online Pharmacies.

Key Takeaways

  • Based on cancer type, the prostate cancer segment accounted for the largest share of the market in 2021 owing to their high prevalence among the Brazilian population. 
  • The rapid rise in awareness among the Brazilian population regarding the importance of early detection and treatment of cancer is driving the market during the forecast period. However, the high cost of cancer therapy is projected to challenge market growth.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Brazil Cancer Therapy Market Report.

Brazil Cancer Therapy Market Share, By Treatment Type, 2021(%)

Brazil Cancer Therapy Market

For More Details on This Report - Request for Sample

Brazil Cancer Therapy Market Segment Analysis - By Cancer Type

Based on Cancer Type, the Brazil Cancer Therapy Market is segmented into Blood Cancer, Bone Cancer, Skin Cancer, Breast Cancer, Colorectal Cancer, Oral Cancer, Gastrointestinal Cancer, Prostate Cancer, Kidney Cancer, Endocrine Cancer, Respiratory Cancer, and Others. The prostate cancer segment is anticipated to have the largest share of the market in 2021 and is poised to dominate the market during the forecast period 2022-2027. This is attributed to the high prevalence of prostate cancer among the Brazilian population. According to the World Health Organization (WHO), prostate cancer accounted for nearly 16.4% of all new cancer cases in 2020. Moreover, prostate cancer accounted for more than 32.4% of cancer cases among males in 2020. The prostate cancer segment is also projected to grow the fastest at a CAGR of 8.8% owing to the rising geriatric population in Brazil.

Brazil Cancer Therapy Market Segment Analysis - By Treatment Type

The Brazil Cancer Therapy Market based on Treatment Type can be further segmented into Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, and Other Treatment Types. The Chemotherapy segment accounted for the largest share of the market in 2021. Chemotherapy involves the use of one or a combination of multiple anti-cancer drugs to destroy cancer cells. The treatment can be given with curative intent, or it may be used to suppress symptoms and increase patient lifespan. Chemotherapy treatment is most commonly performed via intravenous injection. However, they can also be taken as a pill, capsule, cream or liquid by mouth. The targeted therapy segment is anticipated to witness the fastest growth at a CAGR of 9.0% during the forecast period owing to their ability to alter proteins within cancer cells that cause those cells to die.

Brazil Cancer Therapy Market Drivers

Increase in Geriatric Population is Projected to Drive Market Growth.

The proportion of the elderly population in Brazil has grown significantly since 1950. For instance, the geriatric population in 1950 was only around 2.6 million, representing about 4.9% of the population. In 2020, the elderly population reached 30.1 million, representing about 14.3% of the population. Moreover, it is estimated that the geriatric population will reach 73.4 million by 2060. This is anticipated to drive the market for cancer therapy as the geriatric population is more susceptible to cancers. For instance, the median age for the diagnosis of prostate cancer is 66 years. Meanwhile, the median age is 67 years for colorectal cancer and 71 years for lung cancer.

The rise in Lifestyle disorders is Anticipated to Boost Demand

Owing to the growth in disposable income and urbanization in Brazil, more people are following a sedentary lifestyle. This is causing an increase in lifestyle diseases such as obesity and hypertension among the population. For instance, obesity rates increased from only 12.2% in 2003 to around 22.1% in 2021. Moreover, the proportion of the population who are overweight increased from 43.3% in 2003 to 61.7% in 2019. Besides, it is estimated that nearly 40.7% of Brazilians suffer from hypertension. This is driving the demand as obesity and hypertension are major risk factors of cancer.

Brazil Cancer Therapy Market Challenges

The High Cost of Cancer Therapy is Anticipated to Hamper Market Growth

The high cost of cancer therapy is a major challenge that can hamper market growth. According to the US National Institute of Health (NIH), the annual mean cost per patient for cancer therapy in Brazil was $9,572.3, varying from $5,782.1 for breast cancer to $16,656 for cervical cancer. This can make high-quality cancer therapy inaccessible to the vast majority of the population as the average per capita income of the country is estimated to be only around $14,550 in 2020. Besides, even though Brazil provides free public healthcare, the waiting period for medical services can be extremely long as the facilities are often oversubscribed.

COVID-19 Pandemic and Subsequent Restrictions is Projected to Limit Growth Opportunities

The rapid spread of the Covid-19 virus and the rising patient hospitalizations have increased the stress faced by the Brazilian healthcare system. This is challenging the market growth as hospitals are forced to divert funds from other departments including oncology in order to procure essential equipment such as ventilators, PPE kits, masks, ICU beds, and oxygen concentrators for combating the pandemic. At least 22 million people were infected and more than 611,000 people died from the virus. Moreover, the fear of contracting the virus from the hospital environment is causing patients to cancel diagnostic and treatment appointments, further contributing to the decrease in market growth.

Brazil Cancer Therapy Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Brazil Cancer Therapy Market. The top 10 companies of the industry include:

  1. Novartis International
  2. Astra Zeneca
  3. Pfizer Inc.
  4. Bayer Healthcare
  5. EMS
  6. GlaxoSmithKline plc
  7. Sanofi Inc.
  8. Hypermarcas
  9. Eurofarma Corp
  10. F. Hoffmann-La Roche

Partnerships/Product Launches:

  • In December 2020, Servier do Brazil, a Servier Group affiliate announced the launch of their first oncology treatment in the solid tumor field on the Brazilian market. This launch follows the obtention, by Servier do Brazil, of the market authorization delivered on May 2020 by the Brazilian Health Regulatory Agency (ANVISA).
  • In September 2020, Samsung Bioepis announced the launch of their trastuzumab biosimilar Ontruzant in Brazil for the treatment of breast and gastric cancer. Samsung Bioepis’ biosimilar trastuzumab is sold under the trade name Ontruzant and they will be sold in 150 mg single-dose vial
Relevant Links:

LATAM Oncology Drugs Market - Forecast (2022 - 2027)

Report Code: HCR 1474

Cancer Hormone Therapy Market - Forecast (2022 - 2027)

Report Code: HCR 0196

For more Lifesciences and Healthcare Market reports, please click here

1. Brazil Cancer Therapy Market Overview
    1.1 Definitions and Scope
2. Brazil Cancer Therapy Market - Executive Summary
3. Brazil Cancer Therapy Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Brazil Cancer Therapy Market – Start-up Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Brazil Cancer Therapy Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Brazil Cancer Therapy Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Brazil Cancer Therapy Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Brazil Cancer Therapy Market – By Caner Type (Market Size –$Million/$Billion) 
    8.1 Blood Cancer
    8.2 Bone Cancer
    8.3 Skin Cancer
    8.4 Breast Cancer
    8.5 Colorectal Cancer
    8.6 Oral Cancer
    8.7 Gastrointestinal Cancer
    8.8 Prostate Cancer
    8.9 Kidney Cancer
    8.10 Endocrine Cancer
    8.11 Respiratory Cancer
    8.12 Others
9. Brazil Cancer Therapy Market - By Treatment Type (Market Size –$Million/$Billion) 
    9.1 Chemotherapy
    9.2 Targeted Therapy
    9.3 Immunotherapy
    9.4 Hormonal Therapy
    9.5 Radiation Therapy
    9.6 Other Treatment Types
10. Brazil Cancer Therapy Market - By Distribution Channel (Market Size –$Million/$Billion) 
    10.1 Hospitals
    10.2 Clinics
    10.3 Cancer and Radiation Therapy Centers
    10.4 Retail Pharmacies
    10.5 Online Pharmacies
11. Brazil Cancer Therapy Market- Market Entropy
    11.1 New product launches
    11.2 M&A's, collaborations, JVs, and partnerships
12. Brazil Cancer Therapy Market– Industry Competition Landscape (Premium)
    12.1 Competition Matrix
    12.2 Best Practices for Companies
13. Brazil Cancer Therapy Market- Company Analysis
    13.1 Company 1
    13.2 Company 2
    13.3 Company 3
    13.4 Company 4
    13.5 Company 5
    13.6 Company 6
    13.7 Company 7
    13.8 Company 8
    13.9 Company 9
    13.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"
List of Tables:

Table1: Brazil Cancer Therapy Market Overview 2019-2024
Table2: Brazil Cancer Therapy Market Leader Analysis 2018-2019 (US$)
Table3: Brazil Cancer Therapy Market Product Analysis 2018-2019 (US$)
Table4: Brazil Cancer Therapy Market End User Analysis 2018-2019 (US$)
Table5: Brazil Cancer Therapy Market Patent Analysis 2013-2018* (US$)
Table6: Brazil Cancer Therapy Market Financial Analysis 2018-2019 (US$)
Table7: Brazil Cancer Therapy Market Driver Analysis 2018-2019 (US$)
Table8: Brazil Cancer Therapy Market Challenges Analysis 2018-2019 (US$)
Table9: Brazil Cancer Therapy Market Constraint Analysis 2018-2019 (US$)
Table10: Brazil Cancer Therapy Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11: Brazil Cancer Therapy Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12: Brazil Cancer Therapy Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13: Brazil Cancer Therapy Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14: Brazil Cancer Therapy Market Degree of Competition Analysis 2018-2019 (US$)
Table15: Brazil Cancer Therapy Market Value Chain Analysis 2018-2019 (US$)
Table16: Brazil Cancer Therapy Market Pricing Analysis 2019-2024 (US$)
Table17: Brazil Cancer Therapy Market Opportunities Analysis 2019-2024 (US$)
Table18: Brazil Cancer Therapy Market Product Life Cycle Analysis 2019-2024 (US$)
Table19: Brazil Cancer Therapy Market Supplier Analysis 2018-2019 (US$)
Table20: Brazil Cancer Therapy Market Distributor Analysis 2018-2019 (US$)
Table21: Brazil Cancer Therapy Market Trend Analysis 2018-2019 (US$)
Table22: Brazil Cancer Therapy Market Size 2018 (US$)
Table23: Brazil Cancer Therapy Market Forecast Analysis 2019-2024 (US$)
Table24: Brazil Cancer Therapy Market Sales Forecast Analysis 2019-2024 (Units)
Table25: Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table26: Brazil Cancer Therapy Market By Cancer Type, Revenue & Volume, By Blood Cancer, 2019-2024 ($)
Table27: Brazil Cancer Therapy Market By Cancer Type, Revenue & Volume, By Bone Cancer, 2019-2024 ($)
Table28: Brazil Cancer Therapy Market By Cancer Type, Revenue & Volume, By Skin Cancer, 2019-2024 ($)
Table29: Brazil Cancer Therapy Market By Cancer Type, Revenue & Volume, By Breast Cancer, 2019-2024 ($)
Table30: Brazil Cancer Therapy Market By Cancer Type, Revenue & Volume, By Colorectal Cancer, 2019-2024 ($)
Table31: Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table32: Brazil Cancer Therapy Market By Treatment Type, Revenue & Volume, By Chemotherapy, 2019-2024 ($)
Table33: Brazil Cancer Therapy Market By Treatment Type, Revenue & Volume, By Targeted Therapy, 2019-2024 ($)
Table34: Brazil Cancer Therapy Market By Treatment Type, Revenue & Volume, By Hormone Therapy, 2019-2024 ($)
Table35: Brazil Cancer Therapy Market By Treatment Type, Revenue & Volume, By Immunotherapy, 2019-2024 ($)
Table36: Brazil Cancer Therapy Market By Treatment Type, Revenue & Volume, By Radiation Therapy, 2019-2024 ($)
Table37: Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table38: Brazil Cancer Therapy Market By Product, Revenue & Volume, By Skin Gel, 2019-2024 ($)
Table39: Brazil Cancer Therapy Market By Product, Revenue & Volume, By Skin Patch, 2019-2024 ($)
Table40: Brazil Cancer Therapy Market By Product, Revenue & Volume, By Pills, 2019-2024 ($)
Table41: Brazil Cancer Therapy Market By Product, Revenue & Volume, By Suppository, 2019-2024 ($)
Table42: Brazil Cancer Therapy Market By Product, Revenue & Volume, By Nasal Spray, 2019-2024 ($)
Table43: Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table44: Brazil Cancer Therapy Market By Distribution ChannelB, Revenue & Volume, By Hospital, 2019-2024 ($)
Table45: Brazil Cancer Therapy Market By Distribution ChannelB, Revenue & Volume, By Clinic, 2019-2024 ($)
Table46: Brazil Cancer Therapy Market By Distribution ChannelB, Revenue & Volume, By Ambulatory Service, 2019-2024 ($)
Table47: Brazil Cancer Therapy Market By Distribution ChannelB, Revenue & Volume, By Retail/Pharmacy, 2019-2024 ($)
Table48: Brazil Cancer Therapy Market By Distribution ChannelB, Revenue & Volume, By E-Commerce, 2019-2024 ($)
Table49: North America Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table50: North America Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table51: North America Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table52: North America Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table53: South america Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table54: South america Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table55: South america Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table56: South america Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table57: Europe Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table58: Europe Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table59: Europe Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table60: Europe Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table61: APAC Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table62: APAC Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table63: APAC Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table64: APAC Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table65: Middle East & Africa Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table66: Middle East & Africa Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table67: Middle East & Africa Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table68: Middle East & Africa Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table69: Russia Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table70: Russia Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table71: Russia Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table72: Russia Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table73: Israel Brazil Cancer Therapy Market, Revenue & Volume, By Cancer Type, 2019-2024 ($)
Table74: Israel Brazil Cancer Therapy Market, Revenue & Volume, By Treatment Type, 2019-2024 ($)
Table75: Israel Brazil Cancer Therapy Market, Revenue & Volume, By Product, 2019-2024 ($)
Table76: Israel Brazil Cancer Therapy Market, Revenue & Volume, By Distribution ChannelB, 2019-2024 ($)
Table77: Top Companies 2018 (US$) Brazil Cancer Therapy Market, Revenue & Volume
Table78: Product Launch 2018-2019 Brazil Cancer Therapy Market, Revenue & Volume
Table79: Mergers & Acquistions 2018-2019 Brazil Cancer Therapy Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Brazil Cancer Therapy Market 2019-2024
Figure 2: Market Share Analysis for Brazil Cancer Therapy Market 2018 (US$)
Figure 3: Product Comparison in Brazil Cancer Therapy Market 2018-2019 (US$)
Figure 4: End User Profile for Brazil Cancer Therapy Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Brazil Cancer Therapy Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Brazil Cancer Therapy Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Brazil Cancer Therapy Market 2018-2019
Figure 8: Ecosystem Analysis in Brazil Cancer Therapy Market 2018
Figure 9: Average Selling Price in Brazil Cancer Therapy Market 2019-2024
Figure 10: Top Opportunites in Brazil Cancer Therapy Market 2018-2019
Figure 11: Market Life Cycle Analysis in Brazil Cancer Therapy Market
Figure 12: GlobalBy Cancer Type Brazil Cancer Therapy Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Treatment Type Brazil Cancer Therapy Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy Product Brazil Cancer Therapy Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy Distribution ChannelB Brazil Cancer Therapy Market Revenue, 2019-2024 ($)
Figure 16: Global Brazil Cancer Therapy Market - By Geography
Figure 17: Global Brazil Cancer Therapy Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 18: Global Brazil Cancer Therapy Market CAGR, By Geography, 2019-2024 (%)
Figure 19: North America Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 20: US Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 21: US GDP and Population, 2018-2019 ($)
Figure 22: US GDP – Composition of 2018, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Canada Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 25: Canada GDP and Population, 2018-2019 ($)
Figure 26: Canada GDP – Composition of 2018, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 28: Mexico Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 29: Mexico GDP and Population, 2018-2019 ($)
Figure 30: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 32: South America Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil GDP and Population, 2018-2019 ($)
Figure 35: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Venezuela Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 38: Venezuela GDP and Population, 2018-2019 ($)
Figure 39: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Argentina Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 42: Argentina GDP and Population, 2018-2019 ($)
Figure 43: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Ecuador Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 46: Ecuador GDP and Population, 2018-2019 ($)
Figure 47: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Peru Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 50: Peru GDP and Population, 2018-2019 ($)
Figure 51: Peru GDP – Composition of 2018, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Colombia Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 54: Colombia GDP and Population, 2018-2019 ($)
Figure 55: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Costa Rica Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 58: Costa Rica GDP and Population, 2018-2019 ($)
Figure 59: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 61: Europe Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 62: U.K Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 63: U.K GDP and Population, 2018-2019 ($)
Figure 64: U.K GDP – Composition of 2018, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Germany Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 67: Germany GDP and Population, 2018-2019 ($)
Figure 68: Germany GDP – Composition of 2018, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 70: Italy Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 71: Italy GDP and Population, 2018-2019 ($)
Figure 72: Italy GDP – Composition of 2018, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 74: France Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 75: France GDP and Population, 2018-2019 ($)
Figure 76: France GDP – Composition of 2018, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Netherlands Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 79: Netherlands GDP and Population, 2018-2019 ($)
Figure 80: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Belgium Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 83: Belgium GDP and Population, 2018-2019 ($)
Figure 84: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Spain Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 87: Spain GDP and Population, 2018-2019 ($)
Figure 88: Spain GDP – Composition of 2018, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 90: Denmark Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 91: Denmark GDP and Population, 2018-2019 ($)
Figure 92: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 94: APAC Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 95: China Brazil Cancer Therapy Market Value & Volume, 2019-2024
Figure 96: China GDP and Population, 2018-2019 ($)
Figure 97: China GDP – Composition of 2018, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2018-2019 ($) Brazil Cancer Therapy Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 99: Australia Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 100: Australia GDP and Population, 2018-2019 ($)
Figure 101: Australia GDP – Composition of 2018, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 103: South Korea Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 104: South Korea GDP and Population, 2018-2019 ($)
Figure 105: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 107: India Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 108: India GDP and Population, 2018-2019 ($)
Figure 109: India GDP – Composition of 2018, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Taiwan Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 112: Taiwan GDP and Population, 2018-2019 ($)
Figure 113: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Malaysia Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 116: Malaysia GDP and Population, 2018-2019 ($)
Figure 117: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Hong Kong Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 120: Hong Kong GDP and Population, 2018-2019 ($)
Figure 121: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 123: Middle East & Africa Brazil Cancer Therapy Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 124: Russia Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 125: Russia GDP and Population, 2018-2019 ($)
Figure 126: Russia GDP – Composition of 2018, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Israel Brazil Cancer Therapy Market Value & Volume, 2019-2024 ($)
Figure 129: Israel GDP and Population, 2018-2019 ($)
Figure 130: Israel GDP – Composition of 2018, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 132: Entropy Share, By Strategies, 2018-2019* (%) Brazil Cancer Therapy Market
Figure 133: Developments, 2018-2019* Brazil Cancer Therapy Market
Figure 134: Company 1 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 1 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 1 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 2 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 2 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 2 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 3 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 3 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 3 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 4 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 4 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 4 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 5 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 5 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 5 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 6 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 6 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 6 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 7 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 7 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 7 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 8 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 8 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 8 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 9 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 9 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 9 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 10 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 10 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 10 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 11 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 11 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 11 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 12 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 12 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 12 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 13 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 13 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 13 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 14 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 14 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 14 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)
Figure 176: Company 15 Brazil Cancer Therapy Market Net Revenue, By Years, 2018-2019* ($)
Figure 177: Company 15 Brazil Cancer Therapy Market Net Revenue Share, By Business segments, 2018 (%)
Figure 178: Company 15 Brazil Cancer Therapy Market Net Sales Share, By Geography, 2018 (%)